backbone of Indian vaccine।serum institute of India।#mediaplay#adarpoonawalla

Dr. Mr. Cyrus Poonawalla established the Serum Institute of India in 1966 with the goal of producing life-saving immuno -organic products.

https://youtu.be/jt_AOHCZ9d0

Mr. Adar Poonawalla (born 14 January 1981) is the CEO of Serum Institute of India.  Founded in 1966 by his father, Dr. Mr. Cyrus Poonawalla, it is the world's largest vaccine manufacturer in terms of doses produced as of 2017.

  After graduating from the University of Westminster in London, Mr. Adar Poonawalla joined the Serum Institute of India in 2001.

Serum Institute of India Pvt.  Ltd. is now the world's largest vaccine manufacturer in terms of the number of doses produced and sold globally (over 1.5 billion doses).

In 2011, he was appointed CEO of Serum Institute, with full control over the day-to-day operations of the company.
Serum Institute of India has been ranked as India's No. 1 Biotechnology Company.

Mr. Poonawalla then focused on the company's international market and obtained new products licensed and pre-qualified by the World Health Organization for supply to UN agencies.
 
Serum Institute of India manufactures polio vaccine as well as vaccines for diphtheria, tetanus, pertussis, Hib, BCG, R-hepatitis B, measles, mumps and rubella.

In 2016, he was named one of GQ Magazine's 50 Most Influential Young Indians.

Serum Institute of India produces highly specialized life-saving biologics such as vaccines, antisera and other medical specialties using state-of-the-art genetic and cell-based technologies.
It sells its products in more than 140 countries around the world, with 85 percent of its revenue coming from outside the country.

   He was a key figure in the 2012 acquisition of the Netherlands-based state-run vaccine manufacturing company Bilthoven Biologicals.  Poonawalla also serves on the board of GAVI Alliance, a global vaccine alliance.
  He introduced and launched Serum Institute's oral polio vaccine in 2014.
For the production and testing of its life-saving biological substances, Serum Institute of India has established most modern laboratories with high-tech machinery and computerized equipment.

Vaccines manufactured by the Serum Institute are accredited by the World Health Organization in Geneva and are used in their national immunization programs in approximately 170 countries around the world, saving millions of lives.
Poonawalla Bio-Tech Park in Manjari, Pune is of 42 acres.  This state-of-the-art facility aims to meet the highest standards set by MHRA, US-FDA and several regulatory agencies including Europe, Japan and Australia.
  which were in short supply in the country and had to be imported at exorbitant prices.  After that, many life-saving biologics were manufactured at affordable and plentiful prices, resulting in the country becoming self-sufficient for tetanus anti-toxin and anti-snake venom serum, followed by the DTP (Diphtheria, Tetanus and Pertussis) group of vaccines.  Stayed.  , and then the MMR (measles, mumps and rubella) group of vaccines.
Serum Institute of India now has the flexibility to produce vaccines in more than one plant, allowing a large number of doses to be produced in the shortest possible time.
  The company has increased the prices of new vaccines like Hepatitis-B Vaccine, Combination Vaccine, and so on, so that not only Indians, but all underprivileged children around the world are protected.
  world class production facilities
  Creating more than a billion doses of high quality vaccines
Serum Institute of India has achieved several technological milestones, including the establishment of a robotic arm to combat viruses, a cell factory and cell cube for cell growth, and facilities for the production of polysaccharide and recombinant vaccines, as well as  Contains only monoclonal antibodies.
  Serum Institute's quality control laboratories are equipped with a wide range of sophisticated analytical instruments, including HPLC with PDA detector, Fourier transform infra-red spectrophotometer, gas chromatograph, atomic absorption spectrophotometer, real-time PCR, new Dionex, Karl Fischer moisture analyzer  , ELISA Readers, Liquid Particle Counters, Capillary Zone Electrophoresis, Bio-Plex The technical team has created systems to ensure that quality is embedded in the process.

   Serum Institute of India will manufacture products like HPV, Tdap, Monoclonal Antibody/Biosimilar, Rotavirus Vaccine, and Recombinant BCG Vaccine using state-of-the-art technology